Title:
ピロロベンゾジアゼピン抗体複合体及びその使用
Document Type and Number:
Japanese Patent JP2023542412
Kind Code:
A
Abstract:
本明細書の記載は、抗ＣＤ４５－ピロロベンゾジアゼピン抗体－薬物複合体（ＰＢＤ－ＡＤＣ）およびその治療的使用に関する。【選択図】なし
Inventors:
Van Berkel, Patricius Hendricks Cornelis
Amloria, Persis
chester, kelly
Jen, Jenny
Amloria, Persis
chester, kelly
Jen, Jenny
Application Number:
JP2023518940A
Publication Date:
October 06, 2023
Filing Date:
September 22, 2021
Export Citation:
Assignee:
Ardesey Therapeutics Society Anonym
Medimune Limited
Medimune Limited
International Classes:
C07K16/28; A61K31/5517; A61K35/28; A61K39/395; A61K47/68; A61P7/06; A61P25/00; A61P35/00; A61P35/02; A61P37/02
Attorney, Agent or Firm:
Tadashige Ito
Koichi Hirota
Tadahiko Ito
Koichi Hirota
Tadahiko Ito
Previous Patent: Cyclin-dependent kinase 7 (CDK7) non-covalent inhibitor
Next Patent: Alpha protein kinase 1 inhibitors and methods of use
Next Patent: Alpha protein kinase 1 inhibitors and methods of use